Elekta

Report Publication Announcement • Feb 24, 2011

Elekta: Invitation to telephone conference

Stockholm, February 24, 2011

Elekta's interim report for the third quarter 2010/11 will be published on Tuesday, March 8 at around 07.30 CET. A telephone conference will be held the same day at 10.00-11.00 CET.

During the telephone conference, Tomas Puusepp, President and CEO, and Håkan Bergström, CFO, will present the nine months results and answer questions.

To take part in the conference call, please dial in about five minutes in advance.

Call-in numbers for telephone conference March 8 at 10.00-11.00 CET
+44 (0)207 162 0077
+1 334 323 6201
+47 2156 31 20
+33 (0)1 7099 3208
+49 (0)695 8999 0507
+46 (0)8 5052 0110

The teleconference will also be broadcasted over the Internet. Please visit www.elekta.com – Investor Events, or use the direct link: http://webeventservices.stream57.com/20110308elekta

The telephone conference will be available afterwards on instant replay for seven days. Please dial UK: +44 (0)207 031 40 64, Sweden: +46 (0)8 505 203 33, US: +1 954 334 03 42 and use access code 889226.

******

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB Tel: +46 8 587 25 437, +46 70 778 6010, e-mail: stina.thorman@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.